BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33821250)

  • 1. Alterations in T and B cell function persist in convalescent COVID-19 patients.
    Shuwa HA; Shaw TN; Knight SB; Wemyss K; McClure FA; Pearmain L; Prise I; Jagger C; Morgan DJ; Khan S; Brand O; Mann ER; Ustianowski A; Bakerly ND; Dark P; Brightling CE; Brij S; ; Felton T; Simpson A; Grainger JR; Hussell T; Konkel JE; Menon M
    Med; 2021 Jun; 2(6):720-735.e4. PubMed ID: 33821250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of memory T cell subsets and common γ-chain cytokines in convalescent COVID-19 individuals.
    Rajamanickam A; Pavan Kumar N; Pandiaraj AN; Selvaraj N; Munisankar S; Renji RM; Venkataramani V; Murhekar M; Thangaraj JWV; Muthusamy SK; Chethrapilly Purushothaman GK; Bhatnagar T; Ponnaiah M; Ramasamy S; Velusamy S; Babu S
    J Leukoc Biol; 2022 Jul; 112(1):201-212. PubMed ID: 35258122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.
    Liu J; Yang X; Wang H; Li Z; Deng H; Liu J; Xiong S; He J; Feng X; Guo C; Wang W; Zelinskyy G; Trilling M; Sutter K; Senff T; Menne C; Timm J; Zhang Y; Deng F; Lu Y; Wu J; Lu M; Yang D; Dittmer U; Wang B; Zheng X
    mBio; 2021 Apr; 12(2):. PubMed ID: 33906918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients.
    Chen Q; Yu B; Yang Y; Huang J; Liang Y; Zhou J; Li L; Peng X; Cheng B; Lin Y
    Int Immunopharmacol; 2021 Aug; 97():107685. PubMed ID: 33951560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health.
    Townsend L; Dyer AH; Naughton A; Kiersey R; Holden D; Gardiner M; Dowds J; O'Brien K; Bannan C; Nadarajan P; Dunne J; Martin-Loeches I; Fallon PG; Bergin C; O'Farrelly C; Cheallaigh CN; Bourke NM; Conlon N
    Front Immunol; 2021; 12():676932. PubMed ID: 34025675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing.
    Zhao P; Zou J; Zhou F; Zhu Y; Song Q; Yu D; Li X
    Int Immunopharmacol; 2022 Jul; 108():108767. PubMed ID: 35453072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
    Bieberich F; Vazquez-Lombardi R; Yermanos A; Ehling RA; Mason DM; Wagner B; Kapetanovic E; Di Roberto RB; Weber CR; Savic M; Rudolf F; Reddy ST
    Front Immunol; 2021; 12():701085. PubMed ID: 34322127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children.
    Rajamanickam A; Venkataraman A; Kumar NP; Sasidaran R; Pandiarajan AN; Selvaraj N; Mittal R; Gowshika K; Putlibai S; Lakshan Raj S; Ramanan PV; Babu S
    BMC Pediatr; 2023 Apr; 23(1):156. PubMed ID: 37013538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection.
    Aguilar-Jiménez W; Flórez-Álvarez L; Rincón DS; Marín-Palma D; Sánchez-Martínez A; Martínez J; Zapata MI; Loaiza JD; Cárdenas C; Guzmán F; Velilla PA; Taborda NA; Zapata W; Hernández JC; Díaz FJ; Rugeles MT
    Biomedica; 2021 Oct; 41(Sp. 2):86-102. PubMed ID: 34669281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained expression of inflammatory monocytes and activated T cells in COVID-19 patients and recovered convalescent plasma donors.
    Singh R; Hemati H; Bajpai M; Yadav P; Maheshwari A; Kumar S; Agrawal S; Sevak JK; Islam M; Mars JS; Sarin SK; Trehanpati N
    Immun Inflamm Dis; 2021 Dec; 9(4):1279-1290. PubMed ID: 34363351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
    Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2021; 12():687449. PubMed ID: 34322120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection.
    Hou H; Zhang Y; Tang G; Luo Y; Liu W; Cheng C; Jiang Y; Xiong Z; Wu S; Sun Z; Xu S; Fan X; Wang F
    J Allergy Clin Immunol; 2021 Dec; 148(6):1481-1492.e2. PubMed ID: 34536418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection.
    Wiech M; Chroscicki P; Swatler J; Stepnik D; De Biasi S; Hampel M; Brewinska-Olchowik M; Maliszewska A; Sklinda K; Durlik M; Wierzba W; Cossarizza A; Piwocka K
    Front Immunol; 2022; 13():886431. PubMed ID: 35757700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients.
    Papayanni PG; Chasiotis D; Koukoulias K; Georgakopoulou A; Iatrou A; Gavriilaki E; Giannaki C; Bitzani M; Geka E; Tasioudis P; Chloros D; Fylaktou A; Kioumis I; Triantafyllidou M; Dimou-Besikli S; Karavalakis G; Boutou AK; Siotou E; Anagnostopoulos A; Papadopoulou A; Yannaki E
    Clin Infect Dis; 2021 Dec; 73(11):2073-2082. PubMed ID: 33905481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
    Mazzoni A; Salvati L; Maggi L; Capone M; Vanni A; Spinicci M; Mencarini J; Caporale R; Peruzzi B; Antonelli A; Trotta M; Zammarchi L; Ciani L; Gori L; Lazzeri C; Matucci A; Vultaggio A; Rossi O; Almerigogna F; Parronchi P; Fontanari P; Lavorini F; Peris A; Rossolini GM; Bartoloni A; Romagnani S; Liotta F; Annunziato F; Cosmi L
    J Clin Invest; 2020 Sep; 130(9):4694-4703. PubMed ID: 32463803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.
    Kared H; Redd AD; Bloch EM; Bonny TS; Sumatoh H; Kairi F; Carbajo D; Abel B; Newell EW; Bettinotti MP; Benner SE; Patel EU; Littlefield K; Laeyendecker O; Shoham S; Sullivan D; Casadevall A; Pekosz A; Nardin A; Fehlings M; Tobian AA; Quinn TC
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33427749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.